ABOUT this BLOG and How to use it
WELCOME to Stu's Views & MS News, a product of MS Views and News, a Not-for-Profit 501(c3) organization. Founded in 2008. We provide educational Multiple Sclerosis information via live seminars and via the internet.
Key-Note: Our live MS educational seminars average approx 65 people per educational program and SINCE our first program in February 2010, we have hosted more than 70 educational programs.
On this blog -View all to the left and all to the right. Scroll through entire page, to find information that could EMPOWER You. At the Bottom of this page, see informational videos.
Monday, October 8, 2012
Ampyra's worth, being questioned by an insurance carrier
Acorda sinks after insurance provider questions MS drug
Theflyonthewall.com via Yahoo! Finance Mon, 08 Oct 2012 08:41 AM PDT
Acorda Therapeutics (ACOR) is retreating after Group Health, which provides health insurance to over 600,000 people in the Northwest, questioned the necessity of the company's multiple sclerosis treatment, ...
THIS IS B.S. everybody and we need to Voice our concerns.
IF the FDA approved the medications, then they must have found worth in the drug(s)
Click here to read the blog posting about Aetna and Then, Call Aetna to voice your resentment to their decision. The phone numbers are found at that posting.